Cardiac Biomarkers Are Associated With an Increased Risk of Stroke and Death in Patients With Atrial Fibrillation | Zendy

Ziad Hijazi | Zendy; Jonas Oldgren | Zendy; Ulrika Andersson | Zendy; Stuart J. Connolly | Zendy; Michael D. Ezekowitz | Zendy; Stefan H. Hohnloser | Zendy; Paul Reilly | Zendy; Dragoş Vinereanu | Zendy; Agneta Siegbahn | Zendy; Salim Yusuf | Zendy; Lars Wallentin | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Cardiac Biomarkers Are Associated With an Increased Risk of Stroke and Death in Patients With Atrial Fibrillation

Author(s) -

Ziad Hijazi,

Jonas Oldgren,

Ulrika Andersson,

Stuart J. Connolly,

Michael D. Ezekowitz,

Stefan H. Hohnloser,

Paul Reilly,

Dragoş Vinereanu,

Agneta Siegbahn,

Salim Yusuf,

Lars Wallentin

Publication year - 2012

Publication title -

circulation

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 7.795

H-Index - 607

eISSN - 1524-4539

pISSN - 0009-7322

DOI - 10.1161/circulationaha.111.038729

Subject(s) - medicine , atrial fibrillation , hazard ratio , quartile , natriuretic peptide , cardiology , stroke (engine) , troponin , biomarker , troponin i , randomization , proportional hazards model , randomized controlled trial , myocardial infarction , heart failure , confidence interval , mechanical engineering , engineering , biochemistry , chemistry

Cardiac biomarkers are strong predictors of adverse outcomes in several patient populations. We evaluated the prevalence of elevated troponin I and N-terminal pro-B-type natriuretic peptide (NT-proBNP) and their association to cardiovascular events in atrial fibrillation (AF) patients in the Randomized Evaluation of Long-Term Anticoagulation Therapy (RE-LY) trial.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research